2.66
-7.64%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Yidu Tech
Its shares trade on HKEX under the ticker 2158.HK. It has been listed since 15 January 2021. In the fiscal year to 31 March 2026, it reported revenue of CN¥790.5m and net income of CN¥70.2m. At that date it held total assets of CN¥4.30bn and shareholders' equity of CN¥3.63bn.
Yidu Tech, Inc. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-01-15. The firm operates through three segments. The Big Data Platform and Solutions segment is mainly composed of big data platform offerings and other solutions to customers. The Life Science Solutions segment is responsible for providing analysis-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech and medical device companies and other companies. The Health Management Platform and Solutions segment mainly operates research-driven personal health management platforms and provides insurance technology and disease management solutions to insurance companies and agencies. The firm's main data intelligence infrastructure is YiduCore.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 15 Jan 2021
- Employees
- 1,020
- Website
- yidutechgroup.com ↗
Leadership
Pay as last reported
- Ms. Yingying GongExecutive Chairwoman of the Board, since 2014CN¥2.1m
- Mr. Jiming XuChief Executive Officer, Senior Vice President - Life Sciences Solutions, Executive Director, since 2015CN¥16.6m
- Mr. Zhi HeCo-Founder and Chief Innovation OfficerCN¥5.5m
- Ms. Xiaoying FengChief Financial Officer, Executive Director, Joint Company Secretary, since 2023
- Ms. Shi ZhangSenior Vice President (Big Data Platform and Solutions) and Head of Government Affairs, Executive Director, since 2017CN¥10.3m
- Dr. Jun YanChief Technology Officer, since 2017CN¥12.0m
- Dr. Li XieExecutive Director, since 2025
- Ms. Ching Yi LiJoint Company Secretary
- Mr. Ming ZengNon-Executive DirectorCN¥123,000
- Dr. Wei-Ying MaIndependent Non-Executive DirectorCN¥160,000
- Ms. Rongrong PanIndependent Non-Executive DirectorCN¥160,000
- Prof. Linqi ZhangIndependent Non-Executive DirectorCN¥160,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Yidu Tech's Big Data Platform and Solutions segment serves pharmaceutical companies with advanced analytics.
- Yidu Tech's Life Science Solutions segment provides RWE-based research to biotech firms in China.
- Yidu Tech's Health Management Platform and Solutions segment offers disease management to insurance agencies in Beijing.
Weaknesses
- Yidu Tech's IPO listing date was 15 January 2021, which is a fixed point in time.
- Yidu Tech's headquarters city is Beijing, which may limit regional expansion.
- Yidu Tech's employee count of 1020 is relatively small for a Health Care company.
Opportunities
- Yidu Tech's Life Science Solutions segment can expand into new markets within China's Health Care sector.
- Yidu Tech's Health Management Platform and Solutions segment can partner with more insurance companies in Beijing.
- Yidu Tech's Big Data Platform and Solutions segment can leverage YiduCore for global data intelligence.
Threats
- Yidu Tech's Health Care sector faces increasing regulatory scrutiny in China.
- Yidu Tech's Life Science Solutions segment may encounter competition from other data analytics firms.
- Yidu Tech's Big Data Platform and Solutions segment could face data privacy challenges in the Health Care industry.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.